China’s Marriage Policy Shifts, NYC Welcomes New Mayor Amidst Political Rapprochement
Key Takeaways China's marriage registrations surged 22.5% in Q3 2025, reaching 1.61 million, following nationwide reforms in May 2025 that […]
Breaking News
Global Economic Headwinds Mount as Key Sectors Face Pressure
The global economic landscape is showing increasing signs of strain across multiple sectors, from manufacturing and real estate to consumer
Global Financial Landscape Shifts: BOJ Hints at Rate Hike, UK Raids Pensions, Fed Releases Bank Data
Key Takeaways Bank of Japan (BOJ) official Masu signaled a potential interest rate hike before the conclusion of spring wage
U.S. Markets Rally as S&P 500 Nears 6,600; Trump Comments on Ukraine, NYC, and Mamdani; Fitch Issues Neutral Outlook for Banks
Key Takeaways Major U.S. stock indices concluded the trading day significantly higher, with the S&P 500 unofficially closing up 0.94%
International Diplomacy and Central Bank Transparency Mark Recent Developments
Key Takeaways UK Prime Minister Keir Starmer engaged in high-level diplomatic talks with French President Emmanuel Macron and German Chancellor
Global Markets React to Oil Price Dips, Fed Survey, and Shifting U.S. Policies
Key Takeaways Brent Crude futures settled at $62.56 per barrel, marking a 1.29% decline, while U.S. Crude Oil futures fell
AstraZeneca Commits $2 Billion to Maryland Manufacturing; Geopolitical Talks on Ukraine Advance; RFK Jr. Influences CDC Vaccine Language
Key Takeaways AstraZeneca (AZN) announced a substantial $2 billion investment to expand its manufacturing footprint in Maryland, bolstering production of
Market Surges as Trump Team Considers Easing Nvidia Chip Sales to China; Ford Reaffirms Strong Outlook
Key Takeaways The Trump administration is reportedly considering allowing the sale of Nvidia's (NVDA) H200 chips to China, a move
Market Shifts and Geopolitical Tensions: A November 21st Roundup
Key Takeaways The Federal Reserve's overnight reverse repo operation saw a significant decline, with only $2.503 billion taken by 12
FDA Grants Priority Review for Merck-Pfizer Bladder Cancer Combo Amidst Intensifying Ukraine Peace Diplomacy
Key Takeaways The U.S. Food and Drug Administration (FDA) has granted priority review for Merck's (MRK) Keytruda and Pfizer's (PFE)